Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis

医学 甘精胰岛素 血糖性 胰岛素 脱胶胰岛素 胰岛素detemir 低血糖 2型糖尿病 糖化血红素 糖尿病 内科学 荟萃分析 随机对照试验 1型糖尿病 内分泌学
作者
Peng Wang,Yu Zhang,L. Xu,Jialing He,Liyuan Peng,Yuning Feng,Ping Xu,Weelic Chong,Yang Hai,Lu Jia,Fang Fang
出处
期刊:Diabetology & Metabolic Syndrome [BioMed Central]
卷期号:16 (1) 被引量:2
标识
DOI:10.1186/s13098-023-01240-5
摘要

Abstract Background Randomized controlled trials have found that once-weekly insulin resulted in greater glycemic control compared to once-daily insulin in patients with type 2 diabetes. However, no direct comparisons have been made between different types of once-weekly insulin thus far. This systematic review and network meta-analysis aimed to evaluate the effect of the two most advanced once-weekly insulin analogues, namely insulin icodec and insulin Fc, in patients with type 2 diabetes. Methods We conducted a thorough search in the databases PubMed, Embase, and the Cochrane Central Register of Controlled Trials. The search included articles published from the beginning to October 10, 2023, with no language limitations. Our aim was to conduct a systematic review of randomized controlled trials that investigated the effectiveness and safety of once-weekly insulin in individuals with type 2 diabetes. Our primary outcome was to evaluate excellent glycemic control, defined as patients achieving glycated hemoglobin levels below 7%. Results We identified a total of 7 trials involving 2829 patients. The results showed that once-weekly insulin icodec is more effective than once-weekly insulin Fc (RR 1.59 [95% CI 1.08–2.38]), once-daily degludec (RR 1.43 [95% CI 1.14–1.83]), and once-daily glargine (RR 1.15 [95% CI 1.00-1.41]). Moreover, the incidence of severe hypoglycemia was lower with once-weekly insulin icodec compared to once-daily degludec (RR 0.00016 [95% CI 0 to 0.41]). However, no significant difference in the incidence of severe hypoglycemia was observed between once-weekly insulin icodec and once-daily glargine (RR 0.39 [95% CI 0.03 to 4.83]). Conclusions In patients with type 2 diabetes, once-weekly insulin icodec achieved superior glycemic control compared to once-weekly insulin Fc, with no significant difference in the occurrence of hypoglycemia. The ranking probability results have shown that one weekly icodec seems to be the preferred option in patients with type 2 diabetes. Trial registration PROSPERO Identifier: CRD42023470894.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Janmy发布了新的文献求助10
1秒前
赘婿的应助被2567733526采纳,获得10
1秒前
1秒前
xy完成签到,获得积分20
1秒前
AU魏发布了新的文献求助10
1秒前
鲤鱼发布了新的文献求助10
1秒前
yuanrenwudu完成签到,获得积分10
2秒前
lilili的应助被王11采纳,获得10
2秒前
大模型的应助被乌拉呀哈采纳,获得10
2秒前
Gorge发布了新的文献求助10
2秒前
Peng发布了新的文献求助10
3秒前
江波发布了新的文献求助10
3秒前
霸气板栗的应助被fanature采纳,获得10
3秒前
尹冰露完成签到,获得积分10
3秒前
鳹鶛发布了新的文献求助10
4秒前
JamesPei的应助被迷人的鱼采纳,获得10
4秒前
bonnie发布了新的文献求助10
4秒前
许多年以后完成签到,获得积分10
4秒前
扶摇完成签到,获得积分10
5秒前
JamesPei的应助被ridder采纳,获得10
5秒前
5秒前
5秒前
5秒前
5秒前
peterlzb1234567完成签到,获得积分10
5秒前
Maestro_S的应助被柯南采纳,获得10
6秒前
Evangeline993发布了新的文献求助10
6秒前
Jasper的应助被柯南采纳,获得10
6秒前
李爱国的应助被蓉儿采纳,获得10
6秒前
仔细听发布了新的文献求助10
6秒前
slim完成签到,获得积分10
7秒前
田様的应助被Zzzzxs采纳,获得10
7秒前
7秒前
领导范儿的应助被木木采纳,获得10
7秒前
7秒前
7秒前
niumaking完成签到,获得积分10
7秒前
小刘完成签到,获得积分10
7秒前
xucc的应助被yanyue采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8169459
求助须知:如何正确求助?哪些是违规求助? 9562535
关于积分的说明 21766045
捐赠科研通 7761050
什么是DOI,文献DOI怎么找? 3430397
关于科研通互助平台的介绍 2554220
邀请新用户注册赠送积分活动 2475026